AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34189760 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% of 1RM (HSR group)
Number of subjects: 44
Study 32347977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin 3 mg/d (immediate-release) at bedtime
Number of subjects: 4499
Study 32347977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4499
Study 35315918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 1 (130 patients)
Number of subjects: 1238
Study 35315918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 2 (578 patients)
Number of subjects: 1238
Study 35315918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 3 (530 patients)
Number of subjects: 1238
Study 34682623 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol smoking
Number of subjects: 146
Study 34682623 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic deprivation
Number of subjects: 146
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: St(a+) with trypsin-resistant 'N' antigen
Number of subjects: 1001
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequencing of St(a+) individuals
Number of subjects: 1001
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: St(a+) with trypsin-resistant M antigen
Number of subjects: 1001
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: GYP(A-ψB-A) hybrid allele
Number of subjects: 1001
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel GYP(A-ψB-A) allele
Number of subjects: 1001
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel GYP(A-E-A) allele
Number of subjects: 1001
Study 32394466 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel GYP(A-A) allele
Number of subjects: 1001
Study 35614395 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 58
Study 35614395 — intervention group
Group type: COMPARATOR
Intervention: Liberal Fluid Infusion (LFI)
Number of subjects: 58
Study 34516692 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus 2 grams of Docosahexaenoic acid (DHA) + Eicosapentaenoic acid (EPA)
Number of subjects: 30
Study 34516692 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine
Number of subjects: 30
Study 34516692 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus 2 grams of DHA + EPA
Number of subjects: 30
Study 33177323 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 12
Study 33177323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36180962 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended therapy with therapeutic online intervention (TONI) containing 12 transdiagnostic online modules
Number of subjects: 1152
Study 36180962 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face therapy
Number of subjects: 1152
Study 36180962 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended therapy
Number of subjects: 1152
Study 34003937 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 387
Study 34003937 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 387
Study 34003937 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation
Number of subjects: 387
Study 35114141 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant administration of QIV-HD and mRNA-1273 vaccine
Number of subjects: 306
Study 35114141 — intervention group
Group type: COMPARATOR
Intervention: QIV-HD alone
Number of subjects: 306
Study 35114141 — intervention group
Group type: COMPARATOR
Intervention: mRNA-1273 vaccine alone
Number of subjects: 306
Study 34554717 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 122
Study 34554717 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 122
Study 32228743 — intervention group
Group type: COMPARATOR
Intervention: Control diet with no additive (CON)
Number of subjects: 40
Study 32228743 — intervention group
Group type: EXPERIMENTAL
Intervention: Control diet with 0.5 g/day of SDR (SDR0.5)
Number of subjects: 40
Study 32228743 — intervention group
Group type: EXPERIMENTAL
Intervention: Control diet with 1 g/day of SDR (SDR1)
Number of subjects: 40
Study 32228743 — intervention group
Group type: EXPERIMENTAL
Intervention: Control diet with 1.5 g/day of SDR (SDR1.5)
Number of subjects: 40
Study 35652829 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) ingestion (140 mL, ∼12.8 mmol of nitrate)
Number of subjects: 11
Study 35652829 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) ingestion (140 mL)
Number of subjects: 11
Study 35652829 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) ingestion
Number of subjects: 11
Study 32453643 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 98
Study 32453643 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 98
Study 32453643 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted inferior turbinoplasty (MAIT)
Number of subjects: 98
Study 32453643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 32908173 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 88
Study 32908173 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 88
Study 35198533 — intervention group
Group type: EXPERIMENTAL
Intervention: Back propagate neural network
Number of subjects: 45
Study 35198533 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression
Number of subjects: 45
Study 35198533 — intervention group
Group type: EXPERIMENTAL
Intervention: Both acceleration and heart rate
Number of subjects: 45
Study 35198533 — intervention group
Group type: COMPARATOR
Intervention: Back propagate neural network vs Linear regression
Number of subjects: 45
Study 36094222 — intervention group
Group type: EXPERIMENTAL
Intervention: T-Scan™ guided stabilization splint (SS)
Number of subjects: 48
Study 36094222 — intervention group
Group type: COMPARATOR
Intervention: Stabilization splint (SS)
Number of subjects: 48
Study 32833791 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation treatment (n = 23)
Number of subjects: 49
Study 32833791 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (n = 26)
Number of subjects: 49
Study 34033237 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0
Study 34033237 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 0
Study 34033237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35312137 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation-Based Lifestyle Modification (MBLM)
Number of subjects: 81
Study 35312137 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 81
Study 35312137 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 81
Study 32277253 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombocytosis (platelet count ≥ 400⋅10^9/L)
Number of subjects: 300
Study 32277253 — intervention group
Group type: COMPARATOR
Intervention: Normal platelet count
Number of subjects: 300
Study 34102137 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus chemotherapy
Number of subjects: 1581
Study 34102137 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 1581
Study 33223831 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus rhamnosus GG)
Number of subjects: 200
Study 33223831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 33720917 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical taping
Number of subjects: 40
Study 33720917 — intervention group
Group type: COMPARATOR
Intervention: External splints
Number of subjects: 40
Study 32243403 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of ultrasound images without bony roof and cartilage roof measurements by orthopedic surgery residents, specialists, and professors.
Number of subjects: 210
Study 32243403 — intervention group
Group type: COMPARATOR
Intervention: Bony roof and cartilage roof measurements according to the Graf method of hip ultrasonography.
Number of subjects: 210
Study 33495203 — intervention group
Group type: EXPERIMENTAL
Intervention: predictD‐intervention
Number of subjects: 2998
Study 33495203 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 2998
Study 34375323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (Intervention Group) for 12 months
Number of subjects: 80
Study 34375323 — intervention group
Group type: COMPARATOR
Intervention: Routine nutritional support (Control Group) for 12 months
Number of subjects: 80
Study 33008427 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixazomib in combination with cyclophosphamide and dexamethasone (ICD)
Number of subjects: 0
Study 33008427 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide and dexamethasone (CD)
Number of subjects: 0
Study 33008427 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from CD to ICD treatment
Number of subjects: 0
Study 33158369 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO group (alter ICS based on FeNO and LABA based on symptoms)
Number of subjects: 220
Study 33158369 — intervention group
Group type: COMPARATOR
Intervention: Control group (alter treatment based on symptoms)
Number of subjects: 220
Study 33158369 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS step-down
Number of subjects: 220
Study 33158369 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS step-up
Number of subjects: 220
Study 34137783 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy
Number of subjects: 954
Study 34137783 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 40 years
Number of subjects: 954
Study 34137783 — intervention group
Group type: COMPARATOR
Intervention: History of depression
Number of subjects: 954
Study 34137783 — intervention group
Group type: COMPARATOR
Intervention: Worse physical well-being
Number of subjects: 954
Study 34137783 — intervention group
Group type: COMPARATOR
Intervention: Worse social well-being
Number of subjects: 954
Study 34137783 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant use at study baseline
Number of subjects: 954
Study 32553996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led lifestyle intervention program
Number of subjects: 173
Study 32553996 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 173
Study 32482641 — intervention group
Group type: EXPERIMENTAL
Intervention: ePN (45 min enhanced partner notification communication skills counselling and the offer of provider‐assisted referral)
Number of subjects: 1050
Study 32482641 — intervention group
Group type: EXPERIMENTAL
Intervention: RR (45 min risk reduction skills counselling)
Number of subjects: 1050
Study 32482641 — intervention group
Group type: COMPARATOR
Intervention: HE (20 min health education)
Number of subjects: 1050
Study 32482641 — intervention group
Group type: EXPERIMENTAL
Intervention: ePN
Number of subjects: 1050
Study 32482641 — intervention group
Group type: COMPARATOR
Intervention: HE
Number of subjects: 1050
Study 32482641 — intervention group
Group type: EXPERIMENTAL
Intervention: RR
Number of subjects: 1050
Study 34686091 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stratified potassium supplementation (intermittent infusions of 30 mmol/100 mL potassium chloride)
Number of subjects: 0
Study 34686091 — intervention group
Group type: COMPARATOR
Intervention: Enteral potassium supplementation (10% potassium chloride administered orally in a bolus dose)
Number of subjects: 0
Study 34686091 — intervention group
Group type: EXPERIMENTAL
Intervention: High intravenous potassium concentrations
Number of subjects: 0
Study 32827526 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (home-based 45-minute sessions for 5-8 weeks)
Number of subjects: 60
Study 32827526 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training
Number of subjects: 60
Study 32827526 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 60
Study 35504555 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg)
Number of subjects: 16
Study 35504555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 35504555 — intervention group
Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 16
Study 33901870 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 108
Study 33901870 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 108
Study 35025151 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Shenmen (HT 7) and Sanyinjiao (SP 6)
Number of subjects: 90
Study 35025151 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Shenmen (HT 7)
Number of subjects: 90
Study 35025151 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at Sanyinjiao (SP 6)
Number of subjects: 90
Study 33260139 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arginine (6 g)
Number of subjects: 30
Study 33166333 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (25OHD =20 ng/mL, vitamin D deficient)
Number of subjects: 248
Study 33166333 — intervention group
Group type: COMPARATOR
Intervention: Group II (>20 and <30 ng/mL, vitamin D insufficient)
Number of subjects: 248
Study 33166333 — intervention group
Group type: COMPARATOR
Intervention: Group III (25OHD =30 ng/mL, vitamin D sufficient)
Number of subjects: 248
Study 33166333 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower 25OHD levels
Number of subjects: 248
Study 34752902 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus placebo (n = 168)
Number of subjects: 505
Study 34752902 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus placebo (n = 169)
Number of subjects: 505
Study 34752902 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel (n = 168)
Number of subjects: 505
Study 34752902 — intervention group
Group type: COMPARATOR
Intervention: Single antiplatelet therapy (SAPT)
Number of subjects: 505
Study 34752902 — intervention group
Group type: COMPARATOR
Intervention: DAPT
Number of subjects: 505
Study 34752902 — intervention group
Group type: COMPARATOR
Intervention: SAPT
Number of subjects: 505
Study 34038856 — intervention group
Group type: EXPERIMENTAL
Intervention: iASSIST navigation system
Number of subjects: 83
Study 34038856 — intervention group
Group type: COMPARATOR
Intervention: Conventional guide
Number of subjects: 83
Study 35987554 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Therapy (RT)
Number of subjects: 183
Study 35987554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 183
Study 35987554 — intervention group
Group type: COMPARATOR
Intervention: Health Education Control
Number of subjects: 183
Study 32839195 — intervention group
Group type: EXPERIMENTAL
Intervention: Postangiography plasma kidney injury molecule‐1
Number of subjects: 922
Study 32839195 — intervention group
Group type: EXPERIMENTAL
Intervention: Postangiography plasma IL‐18
Number of subjects: 922
Study 32839195 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute changes in plasma IL‐18
Number of subjects: 922
Study 32839195 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative ratios of plasma IL‐18
Number of subjects: 922
Study 32839195 — intervention group
Group type: COMPARATOR
Intervention: Contrast‐associated AKI
Number of subjects: 922
Study 32839195 — intervention group
Group type: COMPARATOR
Intervention: 90-day major adverse kidney events and death
Number of subjects: 922
Study 34015475 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 8256
Study 34015475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8256
Study 32434204 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg upon admission followed by 40 mg/day)
Number of subjects: 709
Study 32434204 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg upon admission followed by 20 mg/day)
Number of subjects: 709
Study 32434204 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin and Rosuvastatin
Number of subjects: 709
Study 35513735 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant whole-brain radiotherapy (WBRT)
Number of subjects: 89
Study 35513735 — intervention group
Group type: COMPARATOR
Intervention: Observation (no WBRT)
Number of subjects: 89
Study 33158826 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference-informed, heterogeneity-focused HIV counselling and testing (HCT) offer with common and targeted options.
Number of subjects: 1200
Study 33158826 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference-informed, heterogeneity-focused HIV counselling and testing (HCT) offer with common and enhanced options.
Number of subjects: 1200
Study 33158826 — intervention group
Group type: COMPARATOR
Intervention: Common option and three predicted 'less preferred' options (active control arm).
Number of subjects: 1200
Study 35943822 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole monotherapy
Number of subjects: 90
Study 35943822 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined itraconazole/isotretinoin therapy
Number of subjects: 90
Study 35943822 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole monotherapy
Number of subjects: 90
Study 33733564 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability to bipolar disorder
Number of subjects: 0
Study 33733564 — intervention group
Group type: COMPARATOR
Intervention: Genetic liability to lifetime cannabis use
Number of subjects: 0
Study 32349752 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstract interface (Kinect)
Number of subjects: 28
Study 32349752 — intervention group
Group type: COMPARATOR
Intervention: Concrete interface (Touchscreen)
Number of subjects: 28
Study 32349752 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CP and control)
Number of subjects: 28
Study 35942462 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee prosthesis (study group)
Number of subjects: 80
Study 35942462 — intervention group
Group type: COMPARATOR
Intervention: Simple knee prosthesis (control group)
Number of subjects: 80
Study 34994118 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite at 22°C
Number of subjects: 45
Study 34994118 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite at 4°C
Number of subjects: 45
Study 34994118 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite at 37°C
Number of subjects: 45
Study 32735335 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy-based group therapy program called Take a Breath, delivered via online videoconferences over 8 weeks (6 sessions).
Number of subjects: 313
Study 32735335 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group receiving treatment as usual, offered the intervention 3 months after randomization.
Number of subjects: 313
Study 32296925 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior SWL through anterior belly wall in supine position with countertraction
Number of subjects: 100
Study 32296925 — intervention group
Group type: COMPARATOR
Intervention: Posterior SWL (standard approach)
Number of subjects: 100
Study 35094679 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone grafting material
Number of subjects: 35
Study 35094679 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone grafts
Number of subjects: 35
Study 32435960 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Colectomy (SILC)
Number of subjects: 200
Study 32435960 — intervention group
Group type: COMPARATOR
Intervention: Multi-Port Laparoscopic Colectomy (MPC)
Number of subjects: 200
Study 36332661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (loading dose 60 mg and two subsequent 30 mg doses at 2 and 5 hours after misoprostol administration)
Number of subjects: 156
Study 36332661 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with usual-care nonsteroidal anti-inflammatory medications ± opioids
Number of subjects: 156
Study 36332661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 156
Study 36332661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 34404292 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone use (SMA) - 30 minutes of social media apps before training sessions
Number of subjects: 24
Study 34404292 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) - 30 minutes of watching TV before training sessions
Number of subjects: 24
Study 32142170 — intervention group
Group type: EXPERIMENTAL
Intervention: High atorvastatin
Number of subjects: 192
Study 32142170 — intervention group
Group type: EXPERIMENTAL
Intervention: High rosuvastatin
Number of subjects: 192
Study 32142170 — intervention group
Group type: EXPERIMENTAL
Intervention: High simvastatin
Number of subjects: 192
Study 32142170 — intervention group
Group type: COMPARATOR
Intervention: Low atorvastatin
Number of subjects: 192
Study 32142170 — intervention group
Group type: COMPARATOR
Intervention: Low rosuvastatin
Number of subjects: 192
Study 32142170 — intervention group
Group type: COMPARATOR
Intervention: Low simvastatin
Number of subjects: 192
Study 35627597 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg/day of Tetraselmis chuii (TC)
Number of subjects: 46
Study 35627597 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day of Tetraselmis chuii (TC)
Number of subjects: 46
Study 35627597 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (200 mg/day of lactose powder)
Number of subjects: 46
Study 34734030 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical prophylaxis
Number of subjects: 410
Study 34734030 — intervention group
Group type: COMPARATOR
Intervention: LMWH-combination-prophylaxis
Number of subjects: 410
Study 32655024 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/d nano-curcumin
Number of subjects: 60
Study 33205682 — intervention group
Group type: EXPERIMENTAL
Intervention: Siponimod
Number of subjects: 0
Study 33205682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35656203 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 A's of Firearm Safety Counseling training
Number of subjects: 29